|Bid||13.77 x 1000|
|Ask||13.79 x 800|
|Day's range||13.51 - 14.08|
|52-week range||6.59 - 23.88|
|Beta (5Y monthly)||0.76|
|PE ratio (TTM)||N/A|
|Earnings date||24 Sep 2020|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||14 Oct 1999|
|1y target est||10.17|
Rite Aid (NYSE: RAD) has announced the appointment of Trent Kruse as senior vice president of investor relations and treasury as the business continues to chart a course toward a thriving future. Rite Aid has appointed a number of senior leaders in recent months to align key personnel with the company’s RxEvolution strategy, which puts the pharmacist at the center of a holistic approach to healthcare and builds a dominant mid-market pharmacy benefit management company.
Rite Aid's (RAD) Q2 results are likely to reflect gains from enhanced digital capabilities to provide essential services, sturdy Elixir performance and solid growth in prescription deliveries.
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.